Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Novel Screen-Based Virtual Reality Tool for Teaching Brain Death Determination: A Pilot Study of the Virtual Reality Brain Death Determination Tool.

Critical care explorations·2026

Same author

Performance of Intracranial Pressure Waveform Morphological Features as Biomarkers of Intracranial Hypertension.

Critical care explorations·2026

Same author

Correction: Risk Factors for Opioid Utilization in Patients with Intracerebral Hemorrhage.

Neurocritical care·2025

Same author

Corrigendum to "Level of consciousness at discharge and associations with outcome after ischemic stroke" [Journal of the Neurological Sciences, Volume 390 (2018): 102-107].

Journal of the neurological sciences·2025

Same author

The miracle dilemma: demystifying a common challenge in neuroprognostication.

Brain : a journal of neurology·2025

Same author

Rebound Hyperkalemia in Hypokalemic Thyrotoxic Periodic Paralysis.

The Neurohospitalist·2025

Search research articles

Related Experiment Video

Updated: May 8, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Myasthenic crisis.

Linda C Wendell¹, Joshua M Levine

¹Department of Neurology, University of Pennsylvania, Philadephia, PA.

The Neurohospitalist

|August 29, 2013

Summary

This summary is machine-generated.

Myasthenic crisis, a severe complication of myasthenia gravis, involves respiratory failure. Critical care advances have reduced mortality, with this review covering its epidemiology, evaluation, and treatments.

Keywords:

autoimmune diseases of the nervous system myasthenia gravis neurocritical care clinical specialty neuromuscular disease clinical specialty

Related Experiment Videos

Last Updated: May 8, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Area of Science:

Neurology
Critical Care Medicine

Background:

Myasthenic crisis is a life-threatening exacerbation of myasthenia gravis.
It leads to profound muscle weakness and respiratory failure, often necessitating mechanical ventilation.
Despite its severity, critical care advancements have improved survival rates.

Purpose of the Study:

To review the epidemiology of myasthenic crisis.
To outline current patient evaluation strategies.
To discuss available therapeutic interventions.

Main Methods:

Literature review of epidemiology, evaluation, and treatment of myasthenic crisis.
Synthesis of information on critical care management.

Main Results:

Myasthenic crisis epidemiology is presented.
Patient evaluation guidelines are discussed.
Therapeutic options including ventilation, medications, and surgery are reviewed.

Conclusions:

Myasthenic crisis remains a significant complication of myasthenia gravis.
Effective management relies on prompt evaluation and comprehensive therapeutic strategies.
Ongoing advances in critical care continue to improve outcomes.